Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 3
2007 20
2008 55
2009 106
2010 151
2011 216
2012 187
2013 151
2014 82
2015 21
2016 11
2017 19
2018 9
2019 57
2020 204
2021 195
2022 183
2023 147
2024 60

Text availability

Article attribute

Article type

Publication date

Search Results

1,571 results

Results by year

Filters applied: . Clear all
Page 1
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial.
Orlando L, Maiello E, Orditura M, Diana A, Antoniol G, Morritti MG, Aieta M, Ciccarese M, Pisconti S, Bordonaro R, Russo A, Febbraro A, Schiavone P, Quaranta A, Caliolo C, Loparco D, Cinefra M, Colucci G, Cinieri S; Gruppo Oncologico dell’Italia Meridionale (GOIM). Orlando L, et al. Breast. 2024 Apr 5;75:103725. doi: 10.1016/j.breast.2024.103725. Online ahead of print. Breast. 2024. PMID: 38615483 Free PMC article.
Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signature.
van Olmen JP, Jacobs CF, Bartels SAL, Loo CE, Sanders J, Vrancken Peeters MTFD, Drukker CA, van Duijnhoven FH, Kok M. van Olmen JP, et al. Breast. 2024 Apr 5;75:103726. doi: 10.1016/j.breast.2024.103726. Online ahead of print. Breast. 2024. PMID: 38599047 Free PMC article.
A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predisposition.
Zemankova P, Cerna M, Horackova K, Ernst C, Soukupova J, Borecka M, Blümcke B, Cerna L, Cerna M, Curtisova V, Dolezalova T, Duskova P, Dvorakova L, Foretova L, Havranek O, Hauke J, Hahnen E, Hodulova M, Hovhannisyan M, Hruskova L, Janatova M, Janikova M, Jelinkova S, Just P, Kosarova M, Koudova M, Krutilkova V, Machackova E, Matejkova K, Michalovska R, Misove A, Nehasil P, Nemcova B, Novotny J, Panczak A, Pesek P, Scheinost O, Springer D, Stastna B, Stranecky V, Subrt I, Tavandzis S, Tureckova E, Vesela K, Vlckova Z, Vocka M, Wappenschmidt B, Zima T, Kleibl Z, Kleiblova P. Zemankova P, et al. Breast. 2024 Mar 25;75:103721. doi: 10.1016/j.breast.2024.103721. Online ahead of print. Breast. 2024. PMID: 38554551 Free PMC article.
French college of gynecologists and obstetricians (CNGOF) recommendations for clinical practice: Place of breast self-examination in screening strategies.
Lavoue V, Favier A, Franck S, Boutet G, Azuar AS, Brousse S, Golfier F, Uzan C, Vaysse C, Molière S, Boisserie-Lacroix M, Kermarrec E, Seror JY, Delpech Y, Luporsi É, Maugard CM, Taris N, Chabbert-Buffet N, Sabah J, Alghamdi K, Fritel X, Mathelin C. Lavoue V, et al. Breast. 2024 Jan 3;75:103619. doi: 10.1016/j.breast.2023.103619. Online ahead of print. Breast. 2024. PMID: 38547580 Free PMC article. Review.
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients.
Miglietta F, Pontolillo L, De Angelis C, Caputo R, Marino M, Bria E, Di Rienzo R, Verrazzo A, Buonerba C, Tortora G, Di Lorenzo G, Del Mastro L, Giuliano M, Montemurro F, Puglisi F, Guarneri V, De Laurentiis M, Scafuri L, Arpino G. Miglietta F, et al. Breast. 2024 Mar 9;75:103713. doi: 10.1016/j.breast.2024.103713. Online ahead of print. Breast. 2024. PMID: 38493590 Free PMC article.
Platinum chemotherapy for early triple-negative breast cancer.
Mason SR, Willson ML, Egger SJ, Beith J, Dear RF, Goodwin A. Mason SR, et al. Breast. 2024 Mar 12;75:103712. doi: 10.1016/j.breast.2024.103712. Online ahead of print. Breast. 2024. PMID: 38492276 Free PMC article. Review.
2023 Year in review: Early breast cancer.
Nader-Marta G, Partridge AH. Nader-Marta G, et al. Breast. 2024 Apr;74:103700. doi: 10.1016/j.breast.2024.103700. Epub 2024 Feb 24. Breast. 2024. PMID: 38422625 Free PMC article.
Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy.
Krug D, Vladimirova V, Untch M, Kühn T, Schneeweiss A, Denkert C, Ataseven B, Solbach C, Gerber B, Tesch H, Golatta M, Seiler S, Heil J, Nekljudova V, Holtschmidt J, Loibl S. Krug D, et al. Breast. 2024 Apr;74:103701. doi: 10.1016/j.breast.2024.103701. Epub 2024 Feb 24. Breast. 2024. PMID: 38422624 Free PMC article.
Effectiveness of hybrid digital breast tomosynthesis/digital mammography compared to digital mammography in women presenting for routine screening at Maroondah BreastScreen: Study protocol for a co-designed, non-randomised prospective trial.
Houssami N, Lockie D, Giles M, Doncovio S, Marr G, Taylor D, Li T, Nickel B, Marinovich ML. Houssami N, et al. Breast. 2024 Apr;74:103692. doi: 10.1016/j.breast.2024.103692. Epub 2024 Feb 21. Breast. 2024. PMID: 38422623 Free PMC article.
Best of the year: Advanced breast cancer in 2023.
Schlam I, Chavez-MacGregor M. Schlam I, et al. Breast. 2024 Apr;74:103677. doi: 10.1016/j.breast.2024.103677. Epub 2024 Feb 14. Breast. 2024. PMID: 38401422 Free PMC article. Review.
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Freyer G, Martinez-Jañez N, Kukielka-Budny B, Ulanska M, Bourgeois H, Muñoz M, Morales S, Calero JB, Cortesi L, Pintér T, Palácová M, Cherciu N, Petru E, Ettl J, de Almeida C, Villanova G, Raymond R, Minh CTT, Rodrigues A, Cazzaniga ME. Freyer G, et al. Breast. 2024 Apr;74:103681. doi: 10.1016/j.breast.2024.103681. Epub 2024 Feb 9. Breast. 2024. PMID: 38377732 Free PMC article. Clinical Trial.
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
Guo X, Zhang J, Gong X, Wang J, Dai H, Jiao D, Ling R, Zhao Y, Yang H, Liu Y, Liu K, Zhang J, Mao D, He J, Yu Z, Liu Y, Fu P, Wang J, Jiang H, Zhao Z, Tian X, Cao Z, Wu K, Song A, Jin F, Fan Z, Liu Z. Guo X, et al. Breast. 2024 Feb;73:103671. doi: 10.1016/j.breast.2024.103671. Epub 2024 Jan 5. Breast. 2024. PMID: 38277714 Free PMC article.
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes.
Dimitrakopoulos FI, Goussia A, Koliou GA, Dadouli K, Batistatou A, Kourea HP, Bobos M, Arapantoni-Dadioti P, Tzaida O, Koletsa T, Chrisafi S, Sotiropoulou M, Papoudou-Bai A, Nicolaou I, Charchanti A, Mauri D, Aravantinos G, Binas I, Res E, Psyrri A, Pectasides D, Bafaloukos D, Koumarianou A, Bompolaki I, Rigakos G, Karanikiotis C, Koutras A, Zagouri F, Gogas H, Fountzilas G. Dimitrakopoulos FI, et al. Breast. 2024 Feb;73:103668. doi: 10.1016/j.breast.2023.103668. Epub 2023 Dec 25. Breast. 2024. PMID: 38176305 Free PMC article.
Corrigendum to 'Assessment of deep learning-based auto-contouring on interobserver consistency in target volume and organs-at-risk delineation for breast cancer: Implications for RTQA program in a multi-institutional study' [The Breast 73 (2024) 103599].
Choi MS, Chang JS, Kim K, Kim JH, Kim TH, Kim S, Cha H, Cho O, Choi JH, Kim M, Kim J, Kim TG, Yeo SG, Chang AR, Ahn SJ, Choi J, Kang KM, Kwon J, Koo T, Kim MY, Choi SH, Jeong BK, Jang BS, Jo IY, Lee H, Kim N, Park HJ, Im JH, Lee SW, Cho Y, Lee SY, Chang JH, Chun J, Lee EM, Kim JS, Shin KH, Kim YB. Choi MS, et al. Breast. 2024 Apr;74:103624. doi: 10.1016/j.breast.2023.103624. Epub 2023 Dec 30. Breast. 2024. PMID: 38161095 Free PMC article. No abstract available.
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
Schwartz M, Ibadioune S, Vacher S, Villy MC, Trabelsi-Grati O, Le Gall J, Caputo SM, Delhomelle H, Warcoin M, Moncoutier V, Bourneix C, Boutry-Kryza N, De Pauw A, Stern MH, Buecher B, Mouret-Fourme E, Colas C, Stoppa-Lyonnet D, Masliah-Planchon J, Golmard L, Bieche I. Schwartz M, et al. Breast. 2024 Feb;73:103620. doi: 10.1016/j.breast.2023.103620. Epub 2023 Dec 10. Breast. 2024. PMID: 38096711 Free PMC article.
Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction.
Tüchler A, De Pauw A, Ernst C, Anota A, Lakeman IMM, Dick J, van der Stoep N, van Asperen CJ, Maringa M, Herold N, Blümcke B, Remy R, Westerhoff A, Stommel-Jenner DJ, Frouin E, Richters L, Golmard L, Kütting N, Colas C, Wappenschmidt B, Rhiem K, Devilee P, Stoppa-Lyonnet D, Schmutzler RK, Hahnen E. Tüchler A, et al. Breast. 2024 Feb;73:103615. doi: 10.1016/j.breast.2023.103615. Epub 2023 Nov 29. Breast. 2024. PMID: 38061307 Free PMC article.
Oncoplastic and reconstructive surgery in SENONETWORK Italian breast centers: lights and shadows.
Ghilli M, Lisa AVE, Salgarello M, Papa G, Rietjens M, Folli S, Curcio A, Ferrari G, Caruso F, Altomare V, Friedman D, De Santis MC, De Rose F, Meduri B, De Felice F, Marino L, Cucciarelli F, Montemezzi S, Panizza P, Belli P, Caumo F, Vinci V, De Santis G, Klinger M, Roncella M; Senonetwork working group. Ghilli M, et al. Breast. 2024 Feb;73:103601. doi: 10.1016/j.breast.2023.103601. Epub 2023 Nov 18. Breast. 2024. PMID: 38043223 Free PMC article.
The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families.
Schreurs MAC, Ramón Y Cajal T, Adank MA, Collée JM, Hollestelle A, van Rooij J, Schmidt MK, Hooning MJ. Schreurs MAC, et al. Breast. 2024 Feb;73:103611. doi: 10.1016/j.breast.2023.103611. Epub 2023 Nov 25. Breast. 2024. PMID: 38039887 Free PMC article.
Assessment of deep learning-based auto-contouring on interobserver consistency in target volume and organs-at-risk delineation for breast cancer: Implications for RTQA program in a multi-institutional study.
Choi MS, Chang JS, Kim K, Kim JH, Kim TH, Kim S, Cha H, Cho O, Choi JH, Kim M, Kim J, Kim TG, Yeo SG, Chang AR, Ahn SJ, Choi J, Kang KM, Kwon J, Koo T, Kim MY, Choi SH, Jeong BK, Jang BS, Jo IY, Lee H, Kim N, Park HJ, Im JH, Lee SW, Cho Y, Lee SY, Chang JH, Chun J, Lee EM, Kim JS, Shin KH, Kim YB. Choi MS, et al. Breast. 2024 Feb;73:103599. doi: 10.1016/j.breast.2023.103599. Epub 2023 Nov 15. Breast. 2024. PMID: 37992527 Free PMC article.
Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody.
Liu B, Xie N, Tian C, Feng R, Hu ZY, Li J, Liu L, Xiao H, Yang X, Zeng M, Wu H, Lu J, Gao J, Hu X, Cao M, Shui Z, Tang Y, Wu T, Ouyang Q. Liu B, et al. Breast. 2023 Dec;72:103597. doi: 10.1016/j.breast.2023.103597. Epub 2023 Nov 1. Breast. 2023. PMID: 37944341 Free PMC article.
Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls.
Johnson KC, Grimm M, Sukumar J, Schnell PM, Park KU, Stover DG, Jhawar SR, Gatti-Mays M, Wesolowski R, Williams N, Sardesai S, Pariser A, Sudheendra P, Tozbikian G, Ramaswamy B, Doto D, Cherian MA. Johnson KC, et al. Breast. 2023 Dec;72:103591. doi: 10.1016/j.breast.2023.103591. Epub 2023 Oct 14. Breast. 2023. PMID: 37871527 Free PMC article.
An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer.
Lee A, Kang T, Kang SH, Park WC, Lim W, Chang MC, Kim HY, Song JY, Lee J, Byun KD, Kim HA, Son GS, Kim JY, Oh SJ, Chung MS, Choi YJ, Shin HJ, Baek JM, Yoo Y, Um E, Choi JH, Kwak BS, Park MH, Lee SH, Kim CS, Lee I, Kim JR, Lee HS, Lim CW. Lee A, et al. Breast. 2023 Dec;72:103585. doi: 10.1016/j.breast.2023.103585. Epub 2023 Oct 2. Breast. 2023. PMID: 37802015 Free PMC article.
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study.
Di Maio M, Bighin C, Schettini F, Ruelle T, Marandino L, Fabi A, De Angelis C, Giuliano M, De Placido P, De Laurentiis M, Riccardi F, Picotto C, Puglisi F, Del Mastro L, Arpino G; Gruppo Italiano Mammella (GIM) Study Group. Di Maio M, et al. Breast. 2023 Dec;72:103583. doi: 10.1016/j.breast.2023.103583. Epub 2023 Sep 25. Breast. 2023. PMID: 37783133 Free PMC article.
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8.
Jerusalem G, Prat A, Salgado R, Reinisch M, Saura C, Ruiz-Borrego M, Nikolinakos P, Ades F, Filian J, Huang N, Mazzei-Abba A, Tolaney SM. Jerusalem G, et al. Breast. 2023 Dec;72:103580. doi: 10.1016/j.breast.2023.103580. Epub 2023 Sep 15. Breast. 2023. PMID: 37741273 Free PMC article. Clinical Trial.
Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy.
Jaikuna T, Osorio EV, Azria D, Chang-Claude J, De Santis MC, Gutiérrez-Enríquez S, van Herk M, Hoskin P, Lambrecht M, Lingard Z, Seibold P, Seoane A, Sperk E, Symonds RP, Talbot CJ, Rancati T, Rattay T, Reyes V, Rosenstein BS, de Ruysscher D, Vega A, Veldeman L, Webb A, West CML, Aznar MC. Jaikuna T, et al. Breast. 2023 Dec;72:103578. doi: 10.1016/j.breast.2023.103578. Epub 2023 Sep 11. Breast. 2023. PMID: 37713940 Free PMC article.
Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA).
Decker T, Lüdtke-Heckenkamp K, Melnichuk L, Hirmas N, Lübbe K, Zahn MO, Schmidt M, Denkert C, Lorenz R, Müller V, Zahm DM, Mundhenke C, Bauer S, Thill M, Seropian P, Filmann N, Loibl S. Decker T, et al. Breast. 2023 Dec;72:103575. doi: 10.1016/j.breast.2023.08.007. Epub 2023 Sep 1. Breast. 2023. PMID: 37690320 Free PMC article. Clinical Trial.
Patient-reported health-related quality of life outcomes following mastectomy for breast cancer, with immediate, delayed or no breast reconstruction: Four-year follow-up from a prospective cohort study.
Dempsey K, Mathieu E, Brennan M, Snook K, Hoffman J, Campbell I, Scarlet J, Flay H, Wong A, Boyle F, King M, Spillane A. Dempsey K, et al. Breast. 2023 Oct;71:122-131. doi: 10.1016/j.breast.2023.08.001. Epub 2023 Aug 6. Breast. 2023. PMID: 37573653 Free PMC article.
'PartBreCon' study. A UK multicentre retrospective cohort study to assess outcomes following PARTial BREast reCONstruction with chest wall perforator flaps.
Agrawal A, Romics L, Thekkinkattil D, Soliman M, Kaushik M, Barmpounakis P, Mortimer C, Courtney CA, Goyal A, Garreffa E, Carmichael A, Lane RA, Rutherford C, Kim B, Achuthan R, Pitsinis V, Goh S, Ray B, Grover K, Vidya R, Murphy J; PartBreCon Collaborators. Agrawal A, et al. Breast. 2023 Oct;71:82-88. doi: 10.1016/j.breast.2023.07.007. Epub 2023 Jul 17. Breast. 2023. PMID: 37544090 Free PMC article.
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy.
Nordenskjöld A, Fohlin H, Rosell J, Bengtsson NO, Fornander T, Hatschek T, Lindman H, Malmström P, Rydén L, Wallgren A, Stål O, Nordenskjöld B. Nordenskjöld A, et al. Breast. 2023 Oct;71:63-68. doi: 10.1016/j.breast.2023.07.010. Epub 2023 Jul 25. Breast. 2023. PMID: 37517154 Free PMC article. Clinical Trial.
Brain metastasis in de novo stage IV breast cancer.
He Y, Shao Y, Chen Q, Liu C, Zhu F, Liu H. He Y, et al. Breast. 2023 Oct;71:54-59. doi: 10.1016/j.breast.2023.07.005. Epub 2023 Jul 14. Breast. 2023. PMID: 37499376 Free PMC article.
Aesthetic results were more satisfactory after oncoplastic surgery than after total breast reconstruction according to patients and surgeons.
Araújo Pereira Lisboa FC, Paulinelli RR, Campos Veras LP, Jubé Ribeiro LF, Pádua Oliveira LF, Sousa Rahal RM, Sousa AG, Freitas-Júnior R, Batista de Sousa J. Araújo Pereira Lisboa FC, et al. Breast. 2023 Oct;71:47-53. doi: 10.1016/j.breast.2023.07.006. Epub 2023 Jul 15. Breast. 2023. PMID: 37487426 Free PMC article.
Barrier films for the prevention of acute radiation dermatitis in breast cancer: A systematic review and meta-analysis of randomised controlled trials.
Dejonckheere CS, Dejonckheere E, Layer JP, Layer K, Sarria GR, Koch D, Abramian A, Kaiser C, Lindner K, Bachmann A, Anzböck T, Röhner F, Schmeel FC, Schmeel LC. Dejonckheere CS, et al. Breast. 2023 Oct;71:31-41. doi: 10.1016/j.breast.2023.07.001. Epub 2023 Jul 5. Breast. 2023. PMID: 37473629 Free PMC article.
Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B).
Masuda H, Tanabe Y, Sakai H, Matsumoto K, Shimomura A, Doi M, Miyoshi Y, Takahashi M, Sagara Y, Tokunaga S, Iwasa T, Niikura N, Yoshimura K, Takano T, Tsurutani J. Masuda H, et al. Breast. 2023 Oct;71:22-28. doi: 10.1016/j.breast.2023.07.003. Epub 2023 Jul 13. Breast. 2023. PMID: 37459790 Free PMC article. Clinical Trial.
Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.
Zaakouk M, Quinn C, Provenzano E, Boyd C, Callagy G, Elsheikh S, Flint J, Millican-Slater R, Gunavardhan A, Mir Y, Makhija P, Di Palma S, Pritchard S, Tanchel B, Rakha E, Atallah NM, Lee AHS, Pinder S, Shaaban AM. Zaakouk M, et al. Breast. 2023 Aug;70:82-91. doi: 10.1016/j.breast.2023.06.005. Epub 2023 Jun 27. Breast. 2023. PMID: 37419078 Free PMC article.
Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial.
Geurts VCM, Voorwerk L, Balduzzi S, Salgado R, Van de Vijver K, van Dongen MGJ, Kemper I, Mandjes IAM, Heuver M, Sparreboom W, Haanen JBAG, Sonke GS, Horlings HM, Kok M. Geurts VCM, et al. Breast. 2023 Aug;70:76-81. doi: 10.1016/j.breast.2023.06.007. Epub 2023 Jun 27. Breast. 2023. PMID: 37393645 Free PMC article. Clinical Trial.
The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.
Caliskan Yildirim E, Atag E, Coban E, Umit Unal O, Celebi A, Keser M, Uzun M, Keskinkilic M, Tanrikulu Simsek E, Sari M, Yavuzsen T. Caliskan Yildirim E, et al. Breast. 2023 Aug;70:56-62. doi: 10.1016/j.breast.2023.06.006. Epub 2023 Jun 14. Breast. 2023. PMID: 37343321 Free PMC article.
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life.
Stewart SF, Slodkowska-Barabasz J, McGeagh L, Moon Z, Brett J, Wells M, Brown MC, Turner M, Horne R, Fenlon D, Rehman F, Cain H, Donnelly P, Harmer V, Turner L, Rose J, Sharp L, Watson E; SWEET Research Team. Stewart SF, et al. Breast. 2023 Aug;70:32-40. doi: 10.1016/j.breast.2023.05.007. Epub 2023 May 27. Breast. 2023. PMID: 37300986 Free PMC article.
Does age affect outcome with breast cancer?
B Jackson E, Gondara L, Speers C, Diocee R, M Nichol A, Lohrisch C, A Gelmon K. B Jackson E, et al. Breast. 2023 Aug;70:25-31. doi: 10.1016/j.breast.2023.06.001. Epub 2023 Jun 2. Breast. 2023. PMID: 37300985 Free PMC article.
Erratum to 'Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes' [The Breast (2023) 102-109].
Glemarec G, Lacaze JL, Cabarrou B, Aziza R, Jouve E, Zerdoud S, De Maio E, Massabeau C, Loo M, Esteyrie V, Ung M, Dalenc F, Izar F, Chira C. Glemarec G, et al. Breast. 2023 Jun;69:424-427. doi: 10.1016/j.breast.2023.03.011. Epub 2023 May 10. Breast. 2023. PMID: 37172498 Free PMC article. No abstract available.
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.
Lazaratos AM, Maritan SM, Quaiattini A, Darlix A, Ratosa I, Ferraro E, Griguolo G, Guarneri V, Pellerino A, Hofer S, Jacot W, Stemmler HJ, van den Broek MPH, Dobnikar N, Panet F, Lahijanian Z, Morikawa A, Seidman AD, Soffietti R, Panasci L, Petrecca K, Rose AAN, Bouganim N, Dankner M. Lazaratos AM, et al. Breast. 2023 Jun;69:451-468. doi: 10.1016/j.breast.2023.04.008. Epub 2023 May 1. Breast. 2023. PMID: 37156650 Free PMC article.
Partial Breast Irradiation.
Meattini I, de Oliveira Franco R, Salvestrini V, Hijal T. Meattini I, et al. Breast. 2023 Jun;69:401-409. doi: 10.1016/j.breast.2023.04.007. Epub 2023 Apr 24. Breast. 2023. PMID: 37116401 Free PMC article. Review.
Patients' experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study.
Bokkers K, Bleiker EMA, Velthuizen ME, Koelemij R, Burgmans JPJ, Klinkenbijl JH, Schouten van der Velden AP, Vermulst N, Huizinga BF, Witkamp AJ, Frakking T, Brohet RM, Aalfs CM, Koole W, Schoenmaeckers EJP, Ausems MGEM. Bokkers K, et al. Breast. 2023 Jun;69:349-357. doi: 10.1016/j.breast.2023.03.017. Epub 2023 Mar 29. Breast. 2023. PMID: 37018966 Free PMC article.
In Honor of Hans-Jörg Senn.
Thürlimann B, Costa A, Cardoso F. Thürlimann B, et al. Breast. 2023 Jun;69:316-317. doi: 10.1016/j.breast.2023.03.002. Epub 2023 Mar 8. Breast. 2023. PMID: 36934671 Free PMC article. No abstract available.
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials.
Pala L, De Pas T, Pagan E, Sala I, Catania C, Zattarin E, Arnone P, Grassi MM, Colleoni M, Wolff AC, Cortes J, Piccart M, Gelber RD, Viale G, Bagnardi V, Conforti F. Pala L, et al. Breast. 2023 Jun;69:258-264. doi: 10.1016/j.breast.2023.02.012. Epub 2023 Mar 2. Breast. 2023. PMID: 36898259 Free PMC article.
Real de-escalation or escalation in disguise?
Banys-Paluchowski M, Rubio IT, Ditsch N, Krug D, Gentilini OD, Kühn T. Banys-Paluchowski M, et al. Breast. 2023 Jun;69:249-257. doi: 10.1016/j.breast.2023.03.001. Epub 2023 Mar 4. Breast. 2023. PMID: 36898258 Free PMC article.
Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program.
Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Gandhi A, et al. Breast. 2023 Apr;68:205-215. doi: 10.1016/j.breast.2023.02.011. Epub 2023 Feb 24. Breast. 2023. PMID: 36863241 Free PMC article.
Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscopy 'Histolog® scanner' for breast margin assessment in comparison with conventional specimen radiography.
Togawa R, Hederer J, Ragazzi M, Bruckner T, Fastner S, Gomez C, Hennigs A, Nees J, Pfob A, Riedel F, Schäfgen B, Stieber A, Lux MP, Heil J, Golatta M. Togawa R, et al. Breast. 2023 Apr;68:194-200. doi: 10.1016/j.breast.2023.02.010. Epub 2023 Feb 22. Breast. 2023. PMID: 36842192 Free PMC article.
Decision regret in breast cancer patients after adjuvant radiotherapy.
Köksal M, Hoppe C, Schröder AK, Scafa D, Koch D, Sarria GR, Leitzen C, Abramian A, Kaiser C, Faridi A, Henkenberens C, Schmeel LC, Giordano FA. Köksal M, et al. Breast. 2023 Apr;68:133-141. doi: 10.1016/j.breast.2023.01.014. Epub 2023 Feb 1. Breast. 2023. PMID: 36758448 Free PMC article.
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target.
Richard F, De Schepper M, Maetens M, Leduc S, Isnaldi E, Geukens T, Van Baelen K, Nguyen HL, Vermeulen P, Van Laere S, Bertucci F, Ueno N, Dirix L, Floris G, Biganzoli E, Desmedt C. Richard F, et al. Breast. 2023 Jun;69:476-480. doi: 10.1016/j.breast.2023.01.010. Epub 2023 Jan 25. Breast. 2023. PMID: 36717329 Free PMC article.
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.
Chan A, Ruiz-Borrego M, Marx G, Chien AJ, Rugo HS, Brufsky A, Thirlwell M, Trudeau M, Bose R, García-Sáenz JA, Egle D, Pistilli B, Wassermann J, Cheong KA, Schnappauf B, Semsek D, Singer CF, Foruzan N, DiPrimeo D, McCulloch L, Hurvitz SA, Barcenas CH. Chan A, et al. Breast. 2023 Feb;67:94-101. doi: 10.1016/j.breast.2022.12.003. Epub 2022 Dec 14. Breast. 2023. PMID: 36702070 Free PMC article.
How I treat HER2-low advanced breast cancer.
Schlam I, Tolaney SM, Tarantino P. Schlam I, et al. Breast. 2023 Feb;67:116-123. doi: 10.1016/j.breast.2023.01.005. Epub 2023 Jan 12. Breast. 2023. PMID: 36669993 Free PMC article. Review.
Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network).
Sebbag C, Rousset-Jablonski C, Coussy F, Ray-Coquard I, Garin C, Evrevin C, Cessot M, Labrosse J, Laot L, Darrigues L, Bobrie A, Sénéchal-Davin C, Espié M, Giacchetti S, Plu-Bureau G, Maitrot-Mantelet L, Gompel A, Santulli P, Asselain B, Hotton J, Coutant C, Guerin J, Decanter C, Mailliez A, Brain E, Dumas E, Sablone L, Seintinelles RN, Reyal F, Hamy AS. Sebbag C, et al. Breast. 2023 Feb;67:62-70. doi: 10.1016/j.breast.2022.12.033. Epub 2022 Dec 31. Breast. 2023. PMID: 36630821 Free PMC article.
Survival and prognostic factors in oligometastatic breast cancer.
van Ommen-Nijhof A, Steenbruggen TG, Capel L, Vergouwen M, Vrancken Peeters MT, Wiersma TG, Sonke GS. van Ommen-Nijhof A, et al. Breast. 2023 Feb;67:14-20. doi: 10.1016/j.breast.2022.12.007. Epub 2022 Dec 14. Breast. 2023. PMID: 36549169 Free PMC article.
Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3.
Rugo HS, Im SA, Joy AA, Shparyk Y, Walshe JM, Sleckman B, Loi S, Theall KP, Kim S, Huang X, Bananis E, Mahtani R, Finn RS, Diéras V. Rugo HS, et al. Breast. 2022 Dec;66:324-331. doi: 10.1016/j.breast.2022.11.005. Epub 2022 Nov 15. Breast. 2022. PMID: 36463643 Free PMC article. Clinical Trial.
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology.
Miglietta F, Cinquini M, Dieci MV, Cortesi L, Criscitiello C, Montemurro F, Del Mastro L, Zambelli A, Biganzoli L, Levaggi A, Delle Piane C, Marchiò C, Calabrese M, Fortunato L, Franco P, Meduri B, Fittipaldo VA, Gori S. Miglietta F, et al. Breast. 2022 Dec;66:293-304. doi: 10.1016/j.breast.2022.10.014. Epub 2022 Oct 29. Breast. 2022. PMID: 36379199 Free PMC article. Review.
Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study.
Sawaki M, Taira N, Uemura Y, Saito T, Baba S, Kobayashi K, Kawashima H, Tsuneizumi M, Sagawa N, Bando H, Takahashi M, Yamaguchi M, Takashima T, Nakayama T, Kashiwaba M, Mizuno T, Yamamoto Y, Iwata H, Toyama T, Tsugawa K, Kawahara T, Mukai H; RESPECT study group. Sawaki M, et al. Breast. 2022 Dec;66:245-254. doi: 10.1016/j.breast.2022.10.017. Epub 2022 Nov 7. Breast. 2022. PMID: 36371994 Free PMC article. Clinical Trial.
Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel.
Mahtani R, Niyazov A, Arondekar B, Lewis K, Rider A, Massey L, Lux MP. Mahtani R, et al. Breast. 2022 Dec;66:236-244. doi: 10.1016/j.breast.2022.10.009. Epub 2022 Oct 18. Breast. 2022. PMID: 36368161 Free PMC article.
1,571 results